ClearPoint Neuro

ClearPoint Neuro (NASDAQ: CLPT) is a commercial-stage medical device company headquartered in Solana Beach, California, focused on platforms for performing minimally invasive surgical procedures in the brain. Its ClearPoint system combines navigation hardware (SmartFrame trajectory device, SmartFlow cannula) and software that guides surgical planning, device alignment, navigation to target, and procedure monitoring; the portfolio also includes the Prism Neuro laser therapy system and the IRRAflow active fluid-exchange platform. The company additionally provides development services to pharmaceutical and medtech partners supporting cell and gene therapy delivery programs. Formerly MRI Interventions, the company renamed to ClearPoint Neuro in February 2020. On August 3, 2026 it reported Q2 2026 revenue of $10.9M (up 18.1% year over year) with profitability still under pressure and a 15% decline in biologics and drug-delivery revenue; the stock fell 16.29% in the following session.